Planta Medica

Planta Medica (commonly abbreviated as Planta Med.) is a peer-reviewed journal published by Georg Thieme Verlag, founded in 1953 in Stuttgart and issued about seventeen times a year. It concentrates on the chemistry, pharmacognosy and pharmacology of medicinal plants and natural products, and European pharmacy experience has met modern natural science method in its pages for a long time.《药用植物》（Planta Medica，常用缩写为 Planta Med.）是由格奥尔格·蒂梅出版社出版的同行评审学术期刊，1953 年创刊于德国斯图加特，每年出版约十七期。该刊专注药用植物与天然产物的化学、生药学及药理研究，欧洲药学的传统经验与现代自然科学方法在这份刊物上长期交汇。

Scope

Planta Medica proceeds from the stance that every claim made for a medicinal plant must be carried through to an identified chemical entity, asking authors to complete the causal chain between traditional use and modern measurement instead of reporting screening activity alone. Its principal subject areas include:Planta Medica 的取稿立场是「药用植物的每一项主张都要落到确凿的化学物质」，要求作者把传统用途与现代数据之间的因果链走完，而非仅报告活性筛选的结果。收文范围覆盖的主要方向包括：

• Natural products chemistry: isolation and structural elucidation of new natural products, confirmation of stereochemistry, and biosynthetic pathways with partial synthesis.天然产物化学： 新天然产物的分离与结构鉴定、立体化学的确证、生物合成途径与天然产物的结构修饰。
• Pharmacognosy and authentication: morphological and microscopic identification of medicinal plants, DNA barcoding, and detection of adulteration and substitutes.生药学与鉴定： 药用植物的形态与显微鉴别、脱氧核糖核酸条形码、掺伪与代用品的检测。
• Pharmacology and toxicology: mechanistic study of extracts and single constituents, pharmacokinetics and bioavailability, and safety assessment with interactions.药理与毒理： 提取物与单体成分的机制研究、药代动力学与生物利用度、安全评价与相互作用。
• Analytical methodology: hyphenated chromatographic and spectroscopic techniques, metabolomics with fingerprinting, and quantification together with stability of active constituents.植物化学方法： 色谱与波谱联用技术、代谢组学与指纹图谱、活性成分的定量与稳定性考察。
• Cultivation and source material: cultivation science and germplasm of medicinal plants, effects of provenance and harvest time, and quality standards with monograph specifications.栽培与基原： 药用植物的栽培学与种质资源、产地与采收期的影响、质量标准与药材的规范。

Research articles and reviews predominate, joined by short communications and thematic clusters, and structures of new compounds must be supported by complete spectroscopic data稿件类型以研究论文与综述为主，另设短篇通讯与专题小辑；本刊要求新化合物的结构与波谱数据齐备，纯描述性而未作功能或机制取向的工作不予考虑。 purely descriptive work without a functional or mechanistic bearing is not considered.

History

• Founding (1953): launched by Hippokrates Verlag in Germany in June 1953 with volume 1, and within a few years it became the principal German-language venue for medicinal plant research.创刊（1953年）： 本刊于 1953 年 6 月由希波克拉底出版社在德国创办，以第 1 卷起算，1956 年成为涉足德语区药用植物研究的主要阵地。
• Publisher transition: Hippokrates Verlag was later folded into Georg Thieme Verlag, moving the editorial office and production under new ownership while the German pharmacognosy orientation was retained.出版方更替： 创刊时的希波克拉底出版社其后并入格奥尔格·蒂梅出版社，本刊的编辑部与印制随之换由后者承担，但其生药学取向被保留。
• Internationalisation: the language of publication shifted progressively from mainly German to mainly English, and subtitle names were adopted to signal an international identity for natural product and medicinal plant research.国际化： 本刊逐步由德文为主体转向以英文发表为主，并起用副刊名以标明其「国际性的天然产物与药用植物研究」的身份。
• Frequency: the publishing rhythm changed several times through the later twentieth century, standing at fifteen issues a year from 2006 and rising to seventeen from 2010, where it has remained.刊期演变： 本刊的出版节奏在二十世纪后半叶几度调整，2006 年起为每年十五期，2010 年起增加至每年十七期并保持至今。
• Metric trend: the impact factor drifted upward from 2.5 in 2017 to 3.0 in 2021 before falling back to 2.1 in 2025, mid-ranked in both medicinal chemistry and plant sciences.指标走势： 影响因子自 2017 年的 2.5 波动上行至 2021 年的 3.0，其后回落至 2025 年的 2.1，在药物化学与植物科学两个类目中均列中游。

Editors

An editor-in-chief directs the journal, with editorial board members divided by subject and referees drawn mainly from natural products chemistry and pharmacology. Manuscripts are submitted online, and those reporting new structures are asked to supply complete spectroscopic data. Neither the publisher nor the board publishes an acceptance rate or review duration for the title.本刊由主编统筹、国际编委会按题材分工，评审人以天然产物化学与药理学专家为主体；稿件经在线系统投递，涉及新结构化合物的稿件会被要求提供完整的波谱数据。出版方与编委会均未公布本刊的录用比例与审稿时长。

• Structural proof: complete nuclear magnetic resonance and high-resolution mass data must be presented for new natural products, and manuscripts with unresolved stereochemistry are generally required to add derivatisation or crystal data.结构确证： 新天然产物的核磁共振与高分辨质谱数据须完整呈交，立体化学存疑的稿件通常须补充衍生化实验或单晶数据。
• Ethics and provenance: submissions involving collection of plant material must state legal provenance and benefit-sharing arrangements, and work without herbarium vouchers struggles to clear the technical check.伦理与来源： 涉及植物材料采集的稿件须说明来源合规与惠益分享安排，缺标本馆收藏凭证的工作难以通过技术审查。
• Tradition and evidence: the journal remains open to modern readings of traditional medicine, but requires pharmacological corroboration rather than citation of classical texts alone.传统与证据： 本刊对传统用药经验的现代阐释保持开放，但要求给出药理学佐证，而非仅转引古籍。